This pilot study evaluated the effects of major autohemotherapy with ozone infusion on reducing growth/differentiation factor-15 (GDF-15) and LDL cholesterol in patients with type-2 diabetes mellitus (T2DM). The treatment, administered twice weekly for 10 sessions, resulted in a significant reduction in GDF-15 and LDL cholesterol levels in the T2DM group,
